Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.

Omeprazole 20 mg once (o.d.) or twice daily (b.d.), clarithromycin 250 mg b.d., and tinidazole 500 mg b.d. for 7 days (OCT) is an effective regimen against Helicobacter pylori, but the effect of 5-nitroimidazole resistance is unclear. We aimed to evaluate this using the disc diffusion technique (Mas...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Gastroenterology Vol. 33; no. 2; pp. 160 - 164
Autores principales: Moayyedi, Paul, Ragunathan, P. L., Mapstone, Nic, Axon, Anthony T. R., Tompkins, David S., Moayyedi, P, Mapstone, N, Axon, A T, Tompkins, D S
Formato: research Journal Article
Publicado: Springer Nature 1998
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=4689852&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 4689852
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09441174
        EJ7
      jtl: Journal of Gastroenterology
      issn: 09441174
      maglogo: N
    pubinfo:
      dt: 1998
      vid: 33
      iid: 2
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        4689852
        4689852
        NLM9605943
        4689852
        10.1007/s005350050064
        NLM9605943
        4689852
      ppf: 160
      ppct: 4
      formats:
      tig:
        atl: Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
      aug:
        au:
          Moayyedi, Paul
          Ragunathan, P. L.
          Mapstone, Nic
          Axon, Anthony T. R.
          Tompkins, David S.
          Moayyedi, P
          Mapstone, N
          Axon, A T
          Tompkins, D S
        affil: Gastroenterology Department, Centre for Digestive Diseases, General Infirmary at Leeds, United Kingdom
      sug:
        subj:
          Antibiotics Therapeutic Use
          Imidazoles Therapeutic Use
          Omeprazole Therapeutic Use
          Gastrointestinal Agents Therapeutic Use
          Helicobacter Infections Drug Therapy
          Imidazoles Pharmacodynamics
          Helicobacter Pylori Drug Effects
          Clarithromycin Therapeutic Use
          Drug Resistance, Microbial
          Gastrointestinal Agents Administration and Dosage
          Imidazoles Administration and Dosage
          Clarithromycin Administration and Dosage
          Aged
          Female
          Human
          Adult
          Antibiotics Administration and Dosage
          Treatment Failure
          Omeprazole Administration and Dosage
          Middle Age
          Male
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Interview Guides
          Aged: 65+ years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Omeprazole 20 mg once (o.d.) or twice daily (b.d.), clarithromycin 250 mg b.d., and tinidazole 500 mg b.d. for 7 days (OCT) is an effective regimen against Helicobacter pylori, but the effect of 5-nitroimidazole resistance is unclear. We aimed to evaluate this using the disc diffusion technique (Mast Diagnostics, Bootle, UK) and E-test (Cambridge Diagnostics Services, Cambridge, UK) to assess 5-nitroimidazole resistance. H. pylori was cultured from antral biopsies of infected patients, as determined by 13C-urea breath test (13C-UBT), histology, and/or rapid urease test. Patients were prescribed OCT and H. pylori eradication was assessed by 13C-UBT at least 4 weeks after completion of therapy. Antibiotic sensitivities to metronidazole and clarithromycin were evaluated by the disc diffusion method and by the measurement of minimum inhibitory concentration (MIC) using the E-test. One hundred and forty-one H. pylori-infected patients were enrolled in the study and the organism was successfully cultured from 119 patients (84%). The overall eradication rate was 125/141 (89%). OCT was successful in 62/69 (90%) patients harboring fully sensitive strains of H. pylori, compared with 42/45 (93%) of patients with strains that were resistant to metronidazole alone (P = 0.74, Fisher's exact test). MIC was assessed in 22 samples. Using a cut-off point of >32 microg/ml to define metronidazole resistance eradication rates were higher against sensitive (9/12; 75%) than resistant (3/10; 30%) strains (P = 0.08, Fisher's exact test). 5-Nitroimidazole resistance assessed by the disc diffusion technique is not helpful in predicting OCT failure, but the E-test may be of value.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N